ZA922777B - Pharmaceutical formulation containing dirithromycin - Google Patents

Pharmaceutical formulation containing dirithromycin

Info

Publication number
ZA922777B
ZA922777B ZA922777A ZA922777A ZA922777B ZA 922777 B ZA922777 B ZA 922777B ZA 922777 A ZA922777 A ZA 922777A ZA 922777 A ZA922777 A ZA 922777A ZA 922777 B ZA922777 B ZA 922777B
Authority
ZA
South Africa
Prior art keywords
pharmaceutical formulation
formulation containing
dirithromycin
containing dirithromycin
tablet containing
Prior art date
Application number
ZA922777A
Other languages
English (en)
Inventor
James Michael Greene
Holly Marie Hankins
Gregory Alan Stephenson
David Dale Wirth
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ZA922777B publication Critical patent/ZA922777B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Formation And Processing Of Food Products (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
ZA922777A 1991-04-29 1992-04-15 Pharmaceutical formulation containing dirithromycin ZA922777B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US69284291A 1991-04-29 1991-04-29

Publications (1)

Publication Number Publication Date
ZA922777B true ZA922777B (en) 1993-10-15

Family

ID=24782254

Family Applications (2)

Application Number Title Priority Date Filing Date
ZA922777A ZA922777B (en) 1991-04-29 1992-04-15 Pharmaceutical formulation containing dirithromycin
ZA922776A ZA922776B (en) 1991-04-29 1992-04-15 Pharmaceutical compounds

Family Applications After (1)

Application Number Title Priority Date Filing Date
ZA922776A ZA922776B (en) 1991-04-29 1992-04-15 Pharmaceutical compounds

Country Status (27)

Country Link
EP (2) EP0511800B1 (sv)
JP (2) JP3333545B2 (sv)
KR (2) KR100194307B1 (sv)
CN (2) CN1030611C (sv)
AT (2) ATE138924T1 (sv)
AU (2) AU646734B2 (sv)
BR (2) BR9201541A (sv)
CA (2) CA2067275C (sv)
CY (2) CY1946A (sv)
CZ (2) CZ282021B6 (sv)
DE (2) DE69211220T2 (sv)
DK (2) DK0511800T3 (sv)
ES (2) ES2093779T3 (sv)
FI (2) FI101795B1 (sv)
GR (2) GR3020439T3 (sv)
HK (2) HK153696A (sv)
HU (2) HU213613B (sv)
IE (2) IE74885B1 (sv)
IL (2) IL101705A (sv)
MX (2) MX9201946A (sv)
MY (2) MY109498A (sv)
NO (2) NO179504C (sv)
NZ (2) NZ242505A (sv)
RU (2) RU2070203C1 (sv)
TW (2) TW216399B (sv)
YU (2) YU44392A (sv)
ZA (2) ZA922777B (sv)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW271400B (sv) * 1992-07-30 1996-03-01 Pfizer
CR5278A (es) * 1995-03-24 1996-07-04 Lilly Co Eli Formulacion oral de 2-metil-tieno-benzodiacepina
DK0915899T3 (da) * 1996-07-29 2004-11-29 Abbott Lab Fremstilling af krystallinsk form II af clarithromycin
CN1230883A (zh) * 1996-09-24 1999-10-06 伊莱利利公司 包衣颗粒制剂
US6390690B1 (en) 2000-05-17 2002-05-21 3M Innovative Properties Company Fiber optic connector for coupling devices on intersecting planes
EP2104680B1 (en) * 2006-12-05 2013-01-09 Bristol-Myers Squibb Company Motilide polymorphs
CN102145008B (zh) * 2010-12-29 2013-06-05 辰欣药业股份有限公司 一种地红霉素药物组合物及其制备方法
CN107151261B (zh) * 2017-06-09 2020-06-12 广州大光制药有限公司 一种地红霉素化合物的晶型及其结晶制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2515075C2 (de) * 1975-04-07 1985-10-24 Dr. Karl Thomae Gmbh, 7950 Biberach Erythromycinderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
AT342770B (de) * 1975-04-07 1978-04-25 Thomae Gmbh Dr K Verfahren zur herstellung neuer erythromycinderivate
EP0184921A3 (en) * 1984-12-08 1986-10-29 Beecham Group Plc Erythromycin derivatives
DE3524572A1 (de) * 1985-07-10 1987-01-15 Thomae Gmbh Dr K Feste arzneimittelformen zur peroralen anwendung enthaltend 9-deoxo-11-deoxy-9,11-(imino(2-(2-methoxyethoxy)ethyliden)-oxy)-(9s)-erythromycin und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
MY114226A (en) 2002-09-30
FI921877A (fi) 1992-10-30
DK0511800T3 (da) 1997-04-21
IL101704A (en) 1998-02-22
EP0511800B1 (en) 1996-10-23
CA2067275C (en) 2002-11-26
HU9203168D0 (en) 1992-12-28
JP3333545B2 (ja) 2002-10-15
CN1066270A (zh) 1992-11-18
CZ282021B6 (cs) 1997-04-16
AU1525592A (en) 1992-11-05
GR3021706T3 (en) 1997-02-28
BR9201541A (pt) 1992-12-01
HU215917B (hu) 1999-03-29
FI101795B (sv) 1998-08-31
NO180450C (no) 1997-04-23
CA2067274A1 (en) 1992-10-30
HUT62595A (en) 1993-05-28
CN1066186A (zh) 1992-11-18
NO921616D0 (no) 1992-04-27
DK0511799T3 (da) 1996-06-24
JPH05117154A (ja) 1993-05-14
DE69214710D1 (de) 1996-11-28
JPH05117289A (ja) 1993-05-14
GR3020439T3 (en) 1996-10-31
HU213613B (en) 1997-08-28
ATE144425T1 (de) 1996-11-15
KR100193742B1 (ko) 1999-06-15
CZ282218B6 (cs) 1997-06-11
NO179504B (no) 1996-07-15
MX9201946A (es) 1992-11-01
CN1069197C (zh) 2001-08-08
CS127792A3 (en) 1992-11-18
KR920019364A (ko) 1992-11-19
CA2067274C (en) 2002-10-15
NO180450B (no) 1997-01-13
IE921346A1 (en) 1992-11-04
IL101705A (en) 1996-01-31
DE69211220D1 (de) 1996-07-11
YU44492A (sh) 1994-06-24
FI921876A0 (fi) 1992-04-27
EP0511799B1 (en) 1996-06-05
IE74885B1 (en) 1997-08-13
NZ242505A (en) 1993-06-25
AU655978B2 (en) 1995-01-19
JP3135672B2 (ja) 2001-02-19
NO179504C (no) 1996-10-23
KR100194307B1 (ko) 1999-06-15
CY1975A (en) 1997-09-05
KR920019365A (ko) 1992-11-19
ATE138924T1 (de) 1996-06-15
TW315371B (sv) 1997-09-11
CS127692A3 (en) 1992-11-18
ES2088098T3 (es) 1996-08-01
IL101704A0 (en) 1992-12-30
NO921616L (no) 1992-10-30
IE921345A1 (en) 1992-11-04
HU9201398D0 (en) 1992-07-28
AU646734B2 (en) 1994-03-03
NO921617L (no) 1992-10-30
NO921617D0 (no) 1992-04-27
YU44392A (sh) 1994-12-28
HUT63956A (en) 1993-11-29
FI101795B1 (sv) 1998-08-31
MX9201944A (es) 1992-11-01
HK153696A (en) 1996-08-16
IE76296B1 (en) 1997-10-08
CY1946A (en) 1992-04-27
HK215096A (en) 1996-12-13
TW216399B (sv) 1993-11-21
DE69211220T2 (de) 1996-11-07
FI921876A (fi) 1992-10-30
DE69214710T2 (de) 1997-03-13
BR9201540A (pt) 1992-12-01
NZ242506A (en) 1993-09-27
ES2093779T3 (es) 1997-01-01
RU2045953C1 (ru) 1995-10-20
MY109498A (en) 1997-02-28
FI921877A0 (fi) 1992-04-27
EP0511799A1 (en) 1992-11-04
RU2070203C1 (ru) 1996-12-10
EP0511800A1 (en) 1992-11-04
IL101705A0 (en) 1992-12-30
ZA922776B (en) 1993-10-15
AU1525792A (en) 1992-11-05
CN1030611C (zh) 1996-01-03
CA2067275A1 (en) 1992-10-30

Similar Documents

Publication Publication Date Title
GR3036937T3 (en) Pharmaceutical formulations.
ZA926020B (en) Pharmaceutical combination formulation.
IL101679A0 (en) Pharmaceutical tablet formulation
GB9114950D0 (en) Pharmaceutical formulation
IL101704A0 (en) Pharmaceutical formulation containing dirithromycin
ZA927506B (en) New drug formulation.
ZA929825B (en) A pharmaceutical formulation.
GB9121304D0 (en) A novel pharmaceutical formulation
GB9112974D0 (en) Pharmaceutical formulation
GB9116467D0 (en) Pharmaceutical formulation